Latent Tuberculosis: all 199 studies
Page 1 of 2. Open to participants first (48), then studies with results posted, then the rest; newest registration first within each.
- Integrating Tuberculosis Treatment Into Community Pharmacies to Improve TB/HIV Outcomes in UgandaNot yet recruitingNCT07840651Not applicable
- Latent Infection Freshmen Tracking for TuberculosisRecruitingNCT07811518Phase 4
- Screening With Portable X-rays for Rapid Recognition of TBRecruitingNCT07737275Not applicable
- Incidence of Tuberculosis in Patients With Autoimmune Rheumatic DiseasesNot yet recruitingNCT07731672Not applicable
- SCAF-TB - Saving Children and Their Families From Tuberculosis: Implementation Research to Improve TB Preventive Treatment Initiation and Completion Rates Among Contact Persons in Tajikistan and TanzaniaNot yet recruitingNCT07714707Not applicable
- COPD-PTB Screening Trial in Henan, ChinaNot yet recruitingNCT07706972Not applicable
- Shaping a Community-based Pathway to Improve TB Surveillance Among African and Hindustan Immigrants Experiencing VulnerabilitiesNot yet recruitingNCT07687121
- Rifapentine-Based Shorter Regimens for Tuberculosis and TB Infection in KazakhstanNot yet recruitingNCT07668479
- Comparative Trial Between Ainuovirine(ANV)/Lamivudine(3TC)/Tenofovir(TDF) and Efavirenz(EFV)/Lamivudine/Tenofovir RegimensNot yet recruitingNCT07631897Phase 4
- Start4All SCREEN-TB PROTOCOLNot yet recruitingNCT07517471Not applicable
- Isoniazid-Related Hepatotoxicity in Clinical Practice: Incidence and PredictorsNot yet recruitingNCT07472348
- Start4All - Start Taking Action for TB Diagnosis (DARE-TB)Not yet recruitingNCT07420881Not applicable
- Burden of Tuberculosis Among Pregnant and Postpartum Women in Guinea-BissauNot yet recruitingNCT07419568Not applicable
- Start Taking Action for Tuberculosis in KidsNot yet recruitingNCT07248423Not applicable
- BPaLMZ for TB MeningitisRecruitingNCT07227779Phase 2
- Prevalence of Latent Tuberculosis Infection Among Hemodialysis PatientsNot yet recruitingNCT07210970
- Parent Study Name: Pulmonary Rehabilitation to Reduce Post-Tuberculosis Morbidity (TB Pure)RecruitingNCT07164742Not applicable
- A Study of Daily Rifapentine Combined With Isoniazid (1HP) for Tuberculosis Prevention in Children Less Than 13 Years of Age With and Without HIVRecruitingNCT07124559Phase 1/2
- Window Prophylaxis for Pediatric Tuberculosis Prevention TrialRecruitingNCT07086820Not applicable
- PRecision biomArker-Guided MAnagement of TuberculosIs Contacts: a Discrete Choice ExperimentRecruitingNCT07024836
- Host Response to Infection by Direct Analysis of Leukocyte Single Cell-type Gene Expression/transcript Abundance, Direct LS-TA. a Prospective Study Will Evaluate the Performance of Direct LS-TA in Triage Febrile Patients Into Major Categories of Infections: Viral, Bacterial or Active Tuberculosis.Not yet recruitingNCT06846645
- Patients With Tuberculosis, Mycobacteriosis or Latent TuberculosisRecruitingNCT06764576
- Detection of Mycobacterium Tuberculosis in Blood of TB Patients and Their Contacts in UgandaEnrolling by invitationNCT06751706
- Evaluation of a Novel Microbiological Diagnostic Test for Latent Mycobacterium Tuberculosis InfectionEnrolling by invitationNCT06728930
- A Systemic Screening for TB Disease in High-risk Groups in BarcelonaRecruitingNCT06706596
- Bedaquiline Roll-out Evidence in Contacts and People Living With HIV to Prevent TBRecruitingNCT06568484Phase 2/3
- Lung Innate Immunity and Microbiome After Tuberculosis ExposureRecruitingNCT06526689
- Introduction of Dispersible 3HP Formulations for TB Preventive Treatment in Children: a Multi-country EvaluationNot yet recruitingNCT06511180
- Shorter and Safer Treatment Regimens for Latent TBRecruitingNCT06498414Phase 2/3
- Effects of Tuberculosis Infection on Development and Function of the PlacentaRecruitingNCT06352970
- Systems Analysis and Improvement Approach to Prevent TBEnrolling by invitationNCT06314386Not applicable
- Multicenter Italian Cohort Study on Tuberculosis in Pediatric AgeRecruitingNCT06289660
- Dolutegravir Pharmacokinetics During Weekly Rifapentine/Isoniazid for TB PreventionRecruitingNCT06281834Phase 1
- Testing Health Workers At Risk to Advance Our Understanding of TB InfectionRecruitingNCT06221488
- Active Screening of Latent Tuberculosis Infection in School Contacts of Active Tuberculosis PatientsRecruitingNCT06033807
- A Novel Therapy With a 1-Month Ultrashort Regimen to Halt Progression From Latent Infection to Active Tuberculosis Among Close Contacts (The TB-YOUTH Study)RecruitingNCT06022146Phase 3
- Prevalence of Latent Tuberculosis Infection in Health-care Workers and StudentsRecruitingNCT05756582
- The Safety, Completion Rate and Prevention Effect by Rifamycin-containing Regimens for Latent Tuberculosis Infection in Patients With Kidney Transplantation: a Prospective Intervention Pilot StudyRecruitingNCT05588492Phase 4
- Safety and Tolerability of Chlorquine in Addition to Anti-tuberculosis TherapyRecruitingNCT05443178Phase 1
- Dolutegravir Pharmacokinetics Among HIV/TB Coinfected Children Receiving Standard and High-dose RifampicinRecruitingNCT05069688Phase 1
- Economic Incentives and vDOT for Latent Tuberculosis InfectionRecruitingNCT05022862Not applicable
- Short-course Rifamycin-based Regimens for Latent Tuberculosis in Patients With End-stage Kidney DiseaseNot yet recruitingNCT05021731Phase 4
- Pre- and Post-treatment Lung Microbiota, Metabolome and Immune Signatures at the Site of Disease in Patients With Active Pulmonary TuberculosisRecruitingNCT04700579
- Comorbidities and Coinfections in Latent TBRecruitingNCT04642755
- Immunological Biomarkers in Tuberculosis ManagementRecruitingNCT04271397Not applicable
- Assessment of the Safety, Tolerability, and Effectiveness of Rifapentine Given Daily for LTBIRecruitingNCT03474029Phase 2/3
- Diagnosis of Tuberculosis in Swiss ChildrenRecruitingNCT03044509
- Training Protocol on the Natural History of TuberculosisRecruitingNCT01212003
- Point-of-care Pharmacogenomic Testing to Optimize Isoniazid Dosing for Tuberculosis PreventionCompletedNCT05413551Phase 1Results posted
- Brief Educational Video for Patients Prescribed LTBI TreatmentCompletedNCT05412212Not applicableResults posted
- Characterization of Tissue-Specific Immune Responses to Bronchoscopic Instillation of Mycobacterial Antigens Into the Human LungCompletedNCT05027958Early Phase 1Results posted
- Adjunctive Acetylsalicylic Acid and Ibuprofen for TuberculosisTerminatedNCT04575519Phase 2Results posted
- Improving Rhode Island's Tuberculosis Preventive Services in Primary CareCompletedNCT04188041Not applicableResults posted
- Options for Delivering Isoniazid-Rifapentine (3HP) for TB Prevention (3HP Options Implementation Trial)CompletedNCT03934931Not applicableResults posted
- Doravirine, Rifapentine and Isoniazid InteractionCompletedNCT03886701Phase 1Results posted
- Tuberculosis Clinical Trials Consortium Study 35CompletedNCT03730181Phase 1/2Results posted
- Nurse-Led Community Health Worker Adherence Model in 3HP Delivery Among Homeless Adults at Risk for TB Infection and HIVCompletedNCT03702049Not applicableResults posted
- Impact of Weekly Administration of Rifapentine and Isoniazid on Steady State Pharmacokinetics of Tenofovir Alafenamide in Healthy Volunteers (YODA)CompletedNCT03510468Phase 1Results posted
- Development of Human Nasal Challenge Models With Microbial Constituents and Grass PollenCompletedNCT02090374Not applicableResults posted
- Safety and Immunogenicity Study of AERAS-456 Vaccine for TuberculosisCompletedNCT01967134Phase 1Results posted
- A Phase I/IIa AERAS-456 in HIV-Negative Adults With & Without Latent Tuberculosis Infection (C-035-456)CompletedNCT01865487Phase 1/2Results posted
- Study 33: Adherence to Latent Tuberculosis Infection Treatment 3HP SAT Versus 3HP DOTCompletedNCT01582711Phase 3Results posted
- Diagnosis of Tuberculosis Infection in Health Care Workers Using Ex-vivo Interferon-gamma AssayCompletedNCT01007396Not applicableResults posted
- Screening for Latent Tuberculosis Infection (LTBI) in US Army RecruitsCompletedNCT00804713Not applicableResults posted
- Clinical Trial to Study 4 Different Doses of the Vaccine RUTI in Healthy VolunteersCompletedNCT00546273Phase 1Results posted
- Intergrated Service Delivery for Lung Health ConditionsActive, not recruitingNCT07816523
- KAP TB in Senior Management Officials of Companies With Increased Silica ExposureCompletedNCT07749872
- Latent Tuberculosis Infection Screening Using QuantiFERON at Pre-Employment Assessment in Hospital Workers CHu NiceCompletedNCT07608601
- C-TST for Diagnosis of Latent Mycobacterium Tuberculosis Infection in IndonesiaCompletedNCT07587164Not applicable
- Pediatric Optimal Tuberculosis Treatment Evaluation and ReassessmentActive, not recruitingNCT07357844
- Pharmacokinetics of Antituberculosis Drugs in Breastfeeding WomenCompletedNCT07069582Phase 1
- Pharmacist-led Digital Interventions to Improve Tuberculosis Treatment AdherenceCompletedNCT07069387Not applicable
- Latent Tuberculosis in Type 2 DiabetesActive, not recruitingNCT06874725Phase 4
- Host Response to Infection by Direct Analysis of Leukocyte Single Cell-type Gene Expression/transcript Abundance, Direct LS-TAActive, not recruitingNCT06838780
- Trochanteric Bursal Repair After a Total Hip Replacement - Are There Benefits During the First 90 DaysCompletedNCT06553508Not applicable
- Analysis of Liver Injury Risk Factors in a Multiethnic Population Treated With Antituberculosis DrugsActive, not recruitingNCT06539455
- Prospective Quality Improvement Project for High-Risk Diabetes PatientsTerminatedNCT06472609Not applicable
- COMPArison of Screening Strategies for Active TuBerculosis (COMPASS-TB)CompletedNCT06408129
- Evaluating the Accuracy of New Tests for TB Infection DiagnosisCompletedNCT06221735Not applicable
- 1HP Versus 3HR in the Treatment of Tuberculosis Infection in VietnamWithdrawnNCT06191692Phase 3
- Evaluation of ТВ/Flu-05Е Vaccine for the Prevention of Tuberculosis Infection in BCG-vaccinated Volunteers Aged 18-50 YearsCompletedNCT05945498Phase 1
- Clinical Study of Recombinant Mycobacterium Tuberculosis Fusion Protein for 65-year-olds and AboveCompletedNCT05899179Phase 3
- Latent Tuberculosis in Healthcare Workers - the Reality of a Portuguese Tertiary HospitalStatus unknownNCT05847491
- Clinical Practice Guidelines Versus Decision-support for Latent Tuberculosis Infection (LTBI) ManagementCompletedNCT05772065Not applicable
- Short-course Regimens for the Treatment of Pulmonary TuberculosisActive, not recruitingNCT05766267Phase 2/3
- Phase IV Clinical Study of Recombinant Mycobacterium Tuberculosis Fusion ProteinCompletedNCT05746611Phase 4
- Point of Care Tests to Identify Opportunistic Infections in Advanced HIV Patients in Mexico CityStatus unknownNCT05685641Not applicable
- Clinical Trial of MicaActive, not recruitingNCT05680415Phase 4
- New Strategies for Assessment of the Persistence of Viable Bacilli in Latent and Active TuberculosisCompletedNCT05621343
- BCG Re-vaccination for Primary Tuberculosis Prophylaxis in the Prison PopulationWithdrawnNCT05541952Phase 4
- One-month Latent Tuberculosis Treatment for Renal Transplant CandidatesActive, not recruitingNCT05411744Phase 4
- Closing -TB GAPs - for People Living With HIV: TB Guidance for Adaptable Patient-Centered ServiceCompletedNCT05342064Not applicable
- BCG Revaccination in Children and AdolescentsSuspendedNCT05330884Phase 3
- Multi-site Cohort Study for the Development of Personalized Pharmacotherapy in Patients With Tuberculosis (TB)Status unknownNCT05280886
- Collision of Three Global Pandemics: the Effect of Tuberculosis and HIV on the Epidemiological, Clinical, Virological and Immunological Trajectory of COVID-19 in Botswana and NamibiaCompletedNCT05268380
- Effect of Integrating Traditional Tuberculosis Care With Modern Health Care on Case DetectionCompletedNCT05236452Not applicable
- Safety and Tolerability of 1 Month Daily (1HP) and 3 Months Weekly (3HP) Isoniazid and Rifapentine With Pharmacokinetics of Dolutegravir (DTG) in Pregnant People With HIVActive, not recruitingNCT05122026Phase 1/2
- Rifampicin Resistance in S. Aureus During and After Treatment for Latent TuberculosisActive, not recruitingNCT05073926
- miRNA in Sweat, a Novel Digital Biomarker for Detection of Active Tuberculosis (TB)WithdrawnNCT05048381
- Pulmonary Aspergillosis in Tuberculosis PatientsActive, not recruitingNCT05045391